Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/24 16:55 | 10/28/24 | BIOE | Health | Drug | Pharmaceutical Preparations | Yan Yin | NV | DOT | CEO | S.m | -455 | 1.41 | 0 | -324 | -80 | 82 | D | ||||||||||||||
10/11/24 13:57 | 6/6/23 | BIOE | Health | Drug | Pharmaceutical Preparations | Yan Yin | CA | DOT | CEO | P.a | 2,500 | 0.5000 | 0 | 5,000 | 56 | 14,000 | D | ||||||||||||||
10/10/24 21:22 | 9/25/24 | BIOE | Health | Drug | Pharmaceutical Preparations | Yan Yin | NV | DOT | CEO | S.m | -107 | 1.16 | 0 | -92 | -1 | 13,684 | D | ||||||||||||||
10/10/24 17:03 | 7/2/24 | BIOE | Health | Drug | Pharmaceutical Preparations | Yan Yin | NV | DOT | CEO | S.am | -1,931 | 8.62 | 0 | -224 | -2 | 13,776 | D | ||||||||||||||
7/17/24 14:44 | 7/2/24 | BIOE | Health | Drug | Pharmaceutical Preparations | Yan Yin | NV | DOT | CEO | S.m | -484 | 8.03 | 0 | -60 | 0 | 18,940 | D | ||||||||||||||
6/3/24 16:41 | 6/6/23 | BIOE | Health | Drug | Pharmaceutical Preparations | Yan Yin | NV | DOT | CEO | P | 2,500 | 0.5000 | 0 | 5,000 | 36 | 19,000 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |